New cocktail aims to shrink tough colorectal tumors
NCT ID NCT06948448
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This Phase 2 trial tests whether adding an experimental drug (ONO-4578) and an immunotherapy (Opdivo) to standard chemotherapy and bevacizumab can shrink tumors better than standard care alone in people with advanced colorectal cancer that is not MSI-high and has PD-L1 expression. About 144 participants will receive one of two doses of the new combination. The main goals are to see how many patients respond and to monitor side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ONO-4578 (an experimental drug) combined with nivolumab (Opdivo), chemotherapy (mFOLFOX6), and bevacizumab
- What this could lead to
- If successful, this could offer a new first-line treatment option for people with a specific type of advanced colorectal cancer, potentially improving tumor shrinkage rates.
- What could go wrong
- This is an early Phase 2 trial with only 144 participants, so results may not apply to everyone. Adding more drugs also raises the risk of side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOU Uni degli Studi Della Campania Lugi Vanvitelli
RECRUITINGNaples, Napoli, Italy
-
Advent Health
RECRUITINGOrlando, Florida, 32803, United States
-
Azienda Socio Sanitaria Territoriale Niguarda
RECRUITINGMilan, Italy, Italy
-
Baylor Scott & White Medical Center
RECRUITINGTemple, Texas, 76508, United States
-
Blue Ridge Cancer Care
RECRUITINGSalem, Virginia, 24153, United States
-
CHU Besançon - Hôpital Jean Minjoz
RECRUITINGBesançon, Doubs, France
-
CHU Bordeaux - Hôpital Haut-Lévêque
RECRUITINGPessac, Gironde, France
-
CHU Poitiers - Hôpital la Milétrie
RECRUITINGPoitiers, Vienne, France
-
Centre Leon Berard
RECRUITINGLyon, Rhone, France
-
Chru De Nantes Hotel-Dieu
RECRUITINGNantes, Loire Atlantique, France
-
Hospital General Universitario de Valencia
RECRUITINGValencia, Valencia, Spain
-
Hospital Regional Universitario de Malaga
RECRUITINGMálaga, Spain, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, Madrid, Spain
-
Hospital Universitario Reina Sofia
RECRUITINGCórdoba, Córdoba, Spain
-
Hospital Universitario Virgen del Rocio
RECRUITINGSeville, Sevilla, Spain
-
Hosptial Universitari Vall d'Hebron
RECRUITINGBarcelona, Barcelona, Spain
-
Hôpital Européen Georges Pompidou
RECRUITINGParis, Paris, France
-
Hôpital Saint-Antoine
RECRUITINGParis, Paris, France
-
Hôpital de la Timone
RECRUITINGMarseille, Marseille, France
-
IOV-Istituto Oncologico
RECRUITINGPadova, Padova, Italy
-
Institut Catala d'Oncologia (H. Germans Trias I Pujol, ICO-Barcelona)
RECRUITINGBadalona, Barcelona, Spain
-
Istituto Clinico Humanitas
RECRUITINGMilan, Italy, Italy
-
Istituto Europeo di Oncologia
RECRUITINGMilan, Italy, Italy
-
Istituto Nazionale Tumori Fondazione G. Pascale
RECRUITINGNaples, Napoli, Italy
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, Canada
-
Kobe City Medical Center General Hospital
RECRUITINGHyōgo, Kobe-shi, Japan
-
May Clinic Rochester
RECRUITINGRochester, Minnesota, 55905, United States
-
Mayo Clinic Arizona
RECRUITINGPhoenix, Arizona, 85054, United States
-
Mayo Clinic Florida
RECRUITINGJacksonville, Florida, 32224, United States
-
National Hospital Organization Osaka National Hospital
RECRUITINGOsaka, Osaka-shi, Japan
-
Osaka General Medical Center
RECRUITINGOsaka, Osaka-shi, Japan
-
Osaka International Cancer Institute
RECRUITINGOsaka, Osaka-shi, Japan
-
Princess Margaret Cancer Centre- University Health Network
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Rocky Mountain Cancer Centers, LLP
RECRUITINGLone Tree, Colorado, 80124, United States
-
The Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43221, United States
-
The Ottawa Hospital Cancer Centre
RECRUITINGOttawa, Ontario, Canada
-
Thomas Jefferson University, Sidney Kimmel Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
USC Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
Virginia Oncology Associates
RECRUITINGNorfolk, Virginia, 23502, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?